LMAT
Lemaitre Vascular
PE ratio, current and historical analysis
- Stocks
- Healthcare
- NASDAQ: LMAT
- PE Ratio
As of Jun 22, 2026, the Lemaitre Vascular stock's price-to-earnings ratio is 32.11. This results from the current EPS of $2.76 and stock price of $88.61. The PE ratio has decreased by 13% from the past four quarters average of 37.0.
LMAT PE ratio history
The PE ratio of Lemaitre Vascular has averaged 39.58 over the last ten years. The current price-to-earnings ratio of 32.11 is 19% less than the historical average. In the past ten years, LMAT's PE ratio reached its highest point in the Jun 2023 quarter at 59.02, when the stock price was $67.28 and the EPS was $1.14. The lowest point was recorded in the Dec 2018 quarter, when it reached 20.03 with a price of $23.64 and an EPS of $1.18.
Lemaitre Vascular PE ratio by year
Maximum annual increase: 137.32% in 2011
Maximum annual decrease: -42.76% in 2018
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2025 | 31.8 | -32.35% | $81.1 | $2.55 |
| 2024 | 47.01 | 12.63% | $92.14 | $1.96 |
| 2023 | 41.74 | -14.75% | $56.76 | $1.36 |
| 2022 | 48.96 | 23.79% | $46.02 | $0.94 |
| 2021 | 39.55 | 2.54% | $50.23 | $1.27 |
| 2020 | 38.57 | -2.38% | $40.5 | $1.05 |
| 2019 | 39.51 | 97.25% | $35.95 | $0.91 |
| 2018 | 20.03 | -42.76% | $23.64 | $1.18 |
| 2017 | 34.99 | -21.3% | $31.84 | $0.91 |
| 2016 | 44.46 | 13.42% | $25.34 | $0.57 |
| 2015 | 39.2 | 22.96% | $17.25 | $0.44 |
| 2014 | 31.88 | -16.41% | $7.65 | $0.24 |
| 2013 | 38.14 | 12.97% | $8.01 | $0.21 |
| 2012 | 33.76 | -20.17% | $5.74 | $0.17 |
| 2011 | 42.29 | 137.32% | $5.92 | $0.14 |
Lemaitre Vascular PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Mar 2026 | 39.55 | 24.37% | $109.17 | $2.76 |
| Dec 2025 | 31.8 | -13.87% | $81.1 | $2.55 |
| Sep 2025 | 36.92 | -6.65% | $87.51 | $2.37 |
| Jun 2025 | 39.55 | -4.77% | $83.05 | $2.1 |
| Mar 2025 | 41.53 | -11.66% | $83.9 | $2.02 |
| Dec 2024 | 47.01 | -5.87% | $92.14 | $1.96 |
| Sep 2024 | 49.94 | 3.18% | $92.89 | $1.86 |
| Jun 2024 | 48.4 | 11.6% | $82.28 | $1.7 |
| Mar 2024 | 43.37 | 3.91% | $66.36 | $1.53 |
| Dec 2023 | 41.74 | -5.76% | $56.76 | $1.36 |
| Sep 2023 | 44.29 | -24.96% | $54.48 | $1.23 |
| Jun 2023 | 59.02 | 7.78% | $67.28 | $1.14 |
| Mar 2023 | 54.76 | 11.85% | $51.47 | $0.94 |
| Dec 2022 | 48.96 | -6.3% | $46.02 | $0.94 |
| Sep 2022 | 52.25 | 17% | $50.68 | $0.97 |
LMAT Price vs fair value
LMAT average PE ratio chart
What this chart measures
The Historical Valuation Regime chart shows where the stock's current valuation sits relative to its own historical valuation range over the selected lookback period.
This is a history-relative tool, not a market-relative percentile. It does not compare the stock to other companies. Instead, it compares each historical valuation reading to the stock's own past readings.
Percentile logic
The threshold lines are calculated them from the stock's real historical values using percentile interpolation. That is why some colored bands are narrow while others are wide: the band widths reflect how the stock actually traded through time.
Regime map
| Historical percentile | Regime | Chart meaning |
|---|---|---|
| 0-10 | Historically Low | Deep cheap zone |
| >10-25 | Below Average | Cheap relative to history |
| >25-75 | Average | Within the normal historical range |
| >75-90 | Above Average | Expensive relative to history |
| >90-100 | Historically High | Extreme or stretched valuation |
How to read each part
| Chart element | What it tells you |
|---|---|
| Main line | The actual historical valuation values over time for the selected metric. |
| Dashed horizontal lines | The stock's computed P10, P25, Median, P75, and P90 thresholds for the selected period. |
| Colored bands | The historical valuation zones between those thresholds. |
| Metric boxes | Current ratio, historical median, current percentile, and current regime. |
| Timeline strip | A condensed regime history showing how the stock moved between cheap, fair, and expensive states across each observation. |
Important metric definitions
Current Percentile is the percentile rank of the latest valid historical observation within the selected lookback range.
Current Regime is assigned directly from the latest observation's percentile bucket using the fixed 10 / 25 / 75 / 90 cutoffs shown above.
How to use it well
This chart is most useful for answering a narrow question: Is this stock trading high, low, or normal relative to its own history? It works best alongside growth, profitability, and forward-looking business analysis, because a stock can deserve a higher or lower regime if its business quality has changed.
Currently, LMAT's PE ratio is lower than the 3, 5 and 10-year averages.
PE comparison
With a P/E of 32.11, LMAT stands above the Healthcare sector average but below the industry average. Looking at its Healthcare sector average of 24.1, Lemaitre Vascular's P/E is 33% higher.
LMAT PE vs peers
LMAT's PE ratio is less than its peer stock EW, but it is above BSX's.
| Stock name | PE ratio | Market cap |
|---|---|---|
| BSX Boston Scientific Corp | 18.76 | $67.2B |
| LMAT Lemaitre Vascular Inc | 33.39 | $2.11B |
| EW Edwards Lifesciences Corp | 45.72 | $49.76B |
| ANGO Angiodynamics Inc | N/A | $518.55M |
| BAX Baxter International Inc | N/A | $10.36B |
| TFX Teleflex Inc | N/A | $5.48B |
Frequently asked questions
What is Lemaitre Vascular's PE ratio?
LMAT stock has a price to earnings ratio of 32.11 as of Jun 22, 2026.
What is the 3-year average PE ratio for Lemaitre Vascular (LMAT)?
The average PE ratio for LMAT stock over the past 3 years is 43.59.
What is the 5-year average PE ratio for Lemaitre Vascular (LMAT)?
The average PE ratio for LMAT stock over the past 5 years is 44.15.
What is the highest PE ratio for LMAT?
Over the last ten years, the quarterly PE ratio reached a historic high of 59.02 in the Jun 2023 quarter.
How does the current PE ratio for LMAT compare to its historical average?
LMAT's price to earnings ratio is currently 19% below its 10-year historical average.
How is LMAT's PE ratio calculated (Lemaitre Vascular PE ratio formula)?
You can calculate the P/E ratio by dividing the most recent stock price by the trailing twelve months earnings per share(EPS). As of today (Jun 22, 2026), Lemaitre Vascular's stock price is $88.61. The earnings per share for the trailing twelve months (TTM) ending Mar 2026 is $2.76. Therefore, Lemaitre Vascular's price to earnings ratio for today is 32.11. PE RATIO(32.11) = STOCK PRICE($88.61) / TTM EPS($2.76)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.